Citius Pharmaceuticals Inc (CTXR)

Finanzdaten der Citius Pharmaceuticals Inc-Aktie (CTXR)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	17.44% 10.97	9.3408	10.12	8.6721	10.69
Operating Income/Loss	17.44% -10.97	-9.3408	-10.12	-8.6721	-10.69
Nonoperating Income/Loss	913.27% 2.57	0.2536	-	-	-
Income/Loss From Continuing Operations Before Tax	7.56% -8.4002	-9.0872	-9.7999	-8.3353	-10.38
Income Tax Expense/Benefit, Deferred	0.00% 0.144	0.144	0.144	0.144	0.144
Income Tax Expense/Benefit	0.00% 0.144	0.144	0.144	0.144	0.144
Income/Loss From Continuing Operations After Tax	7.44% -8.5442	-9.2312	-9.9439	-8.4793	-10.53
Net Income/Loss	7.44% -8.5442	-9.2312	-9.9439	-8.4793	-10.53
Preferred Stock Dividends And Other Adjustments	-	-	1.1512	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.07% 159.07	158.96	2.5487	153.78	146.25
Diluted Average Shares	0.07% 159.07	158.96	2.5487	153.78	146.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	1.1512	-	-